Prospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Endosc. Feb 16, 2025; 17(2): 101284
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.101284
Table 1 Histologic assessment of biopsies collected from patients with ileal Crohn’s disease with or without an endoscopically visible ulcer in the terminal ileum, n (%)/mean ± SD
HistologyUlcer group
No ulcer controls
Ulcer edge
7 mm from ulcer
14 mm from ulcer
Total sample
Ulcer subscore18 (33)000
Active (neutrophilic) histologic inflammation216 (67)7 (29)4 (17)3 (8)
Chronic (lymphoplasmacytic) histologic inflammation311 (46)5 (21)2 (8)1 (3)
RHI
Total sample11.1 ± 10.62.0 ± 2.91.5 ± 3.10.9 ± 1.7
Subset with active histologic inflammation216.6 ± 8.86.1 ± 1.27.5 ± 3.96 ± 0
GHAS
Total sample6.5 ± 4.82.3 ± 3.21.9 ± 2.71.1 ± 1.9
Subset with active histologic inflammation28.8 ± 3.75.3 ± 2.86.3 ± 2.85.7 ± 1.2
PHRI
Total sample1.9 ± 1.60.4 ± 0.70.4 ± 0.80.1 ± 0.5
Subset with active histologic inflammation22.9 ± 1.11.1 ± 0.91.8 ± 0.51.3 ± 1.2
Large (0.5-2 cm) or very large (> 2 cm) ulcers4
Ulcer subscore18 (42)00
Active (neutrophilic) inflammation216 (84)6 (32)4 (21)
Chronic (lymphoplasmacytic) inflammation311 (58)4 (21)2 (11)
Aphthous ulcers (0.1-0.5 cm)5
Ulcer subscore1000
Active (neutrophilic) inflammation201 (20)0
Chronic (lymphoplasmacytic) inflammation301 (20)0